Papapetropoulos, Spyridon,Savola, Juha-Matti,Eyal, Eli,Borowsky, Beth,Grachev, Igor D.
申请号：
AU2020223736
公开号：
AU2020223736A1
申请日:
2020.08.27
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
#$%^&*AU2020223736A120200917.pdf#####USE OF PRIDOPIDINE FOR TREATING FUNCTIONAL DECLINE ABSTRACT OF THE DISCLOSURE ) This invention provides a method of maintaining functional capacity, improving functional capacity, or lessening the decline of functional capacity in a human patient comprising periodically orally 5 administering to the patient a pharmaceutical composition comprising pridopidine such that a dose of 90-225 mg of pridopidine is administered to the patient per day, so as to thereby maintain functional capacity, improve functional capacity, or lessen the decline of functional capacity in the human patient. 16276016_1 (GHMatters) P44947AU01
